A Trial of PX-12 in Patients With a Histologically or Cytologically Confirmed Diagnosis of Advanced or Metastatic Cancer

NCT00736372 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

14

Enrollment

INDUSTRY

Sponsor class

Conditions

Metastatic Cancer
Advanced Cancer

Interventions

DRUG: PX-12

Sponsor

Cascadian Therapeutics Inc.